Role of microparticles in recurrent miscarriages and other adverse pregnancies: a review

Shrimati Shetty1, Rucha Patil, Kanjaksha Ghosh

  • 1National Institute of Immunohaematology (ICMR), 13th Floor, KEM Hospital, Parel, Mumbai, India. shrimatishetty@gmail.com

Insights

Microparticles (MPs) are linked to pregnancy complications like recurrent miscarriage and preeclampsia. While some studies show increased MPs in recurrent miscarriage, others find no association, unlike the consistent link with preeclampsia.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Cell Biology

Background:

  • Microparticles (MPs) are cell-derived vesicles with diverse biological functions, including roles in coagulation, inflammation, and intercellular communication.
  • Their prothrombotic nature has implicated them in various thrombotic disorders.
  • MPs have garnered significant research interest due to their multifaceted roles.

Observation:

  • A systematic review of MEDLINE and EMBASE databases explored the association between MPs and recurrent miscarriage (RM).
  • Contradictory findings were noted regarding MPs in RM, with most studies reporting increased prevalence (platelet and endothelial cell-derived MPs), but some showing no significant association.
  • A consistent and strong association was observed between MPs and preeclampsia (PE), while links to other adverse pregnancy conditions were less conclusive.

Findings:

  • The prevalence of microparticles (MPs), particularly those derived from platelets and endothelial cells, shows a complex and sometimes contradictory association with recurrent miscarriage (RM).
  • A robust correlation exists between elevated levels of MPs and preeclampsia (PE).
  • The role of MPs in other adverse pregnancy outcomes requires further investigation.

Implications:

  • Microparticles may contribute to adverse pregnancy conditions independently or act as additive factors in women with pre-existing thrombophilia.
  • Understanding the role of MPs in pregnancy complications like RM and PE could lead to improved diagnostic markers and therapeutic strategies.
  • Further research is needed to elucidate the precise mechanisms by which MPs influence pregnancy outcomes and to clarify their association with RM.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...